Clinical Trial

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The ad-ESD trial is phase III randomized trial to compare adjuvant esophagectomy and chemoradiation for patients with clinical stage N0 and pathological stage T1b squamous cell carcinoma (after endoscopic submucosal dissection).
Trial Details
NCT Number NCT04135664
Lead Sponsor Shanghai Chest Hospital
Conditions Esophageal Cancer
Enrollment 176 participants
Start Date 2019-09-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2019-10-22